Navigation Links
Sociological research shows combined impact of genetics, social factors on delinquency
Date:7/14/2008

CHAPEL HILL, NC In one of the first studies to link molecular genetic variants to adolescent delinquency, sociological research published in the August issue of the American Sociological Review identifies three genetic predictorsof serious and violent delinquencythat gain predictive precision when considered together with social influences, such as family, friends and school processes.

Sociologists from the University of North Carolina-Chapel Hill explored the interaction of genetics and social influences and identified three genetic polymorphisms thatwhen examined in the context of modulating social controlsare significant predictors of delinquency. These findings about geneenvironment interactions suggest that certain genotypes and specific social control influences (e.g., family characteristics and processes; popularity and friendship characteristics; and school attendance factors) are mutually dependent on delinquency.

While many behavioral studies of geneenvironment interactions typically examine the relationship of a single factor (e.g., child abuse, stress) to genes, the present research is unique in that it systematically examines layers of social context simultaneously (i.e., family dynamics, peer relations, and school-related variables). The study uses regression analysis to reveal non-intuitive and complex relations among the researched variables.

"While genetics appear to influence delinquency, social influences such as family, friends and school seem to impact the expression of certain genetic variants," said Guang Guo, the study's lead author and a professor of sociology and faculty fellow at the University of North Carolina-Chapel Hill's Carolina Population Center and Carolina Center for Genomic Sciences. "Positive social influences appear to reduce the delinquency-increasing effect of a genetic variant, whereas the effect of these genetic variants is amplified in the absence of social controls."

"Ou
'/>"/>

Contact: Jackie Cooper
jcooper@asanet.org
202-247-9871
American Sociological Association
Source:Eurekalert

Page: 1 2

Related biology news :

1. Louisiana Tech researchers feature drug reformulation in prestigious journal
2. UCLA researchers locate and image prostate cancer as it spreads to lymph nodes
3. UCSB researcher leads worldwide study on marine fossil diversity
4. National Institutes of Health award Williams professor $217,710 research grant
5. Charcot-marie-tooth disease research funding
6. Glenn Foundation for Medical Research commits $5 million to study aging
7. Researchers catch ion channels in their opening act
8. UGA researchers discover mechanism that explains how cancer enzyme winds up on ends of chromosomes
9. Researchers hack final part of the immune system code
10. Revolutionary chefs? Not likely, shows physics research
11. Scripps research scientists reveal key structure from ebola virus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...of Biology Teachers (NABT) will recognize Leonard ...Naugatuck Valley Community College (NVCC) in Water...on Award during the NABT annual professional devel...n Denver, Colorado. , The Evolution Education Aw...ological Sciences,(AIBS) and Biological Sciences ...
(Date:11/5/2009)... been awarded a training grant in the amount of $2...its Integrative Graduation Education and Research ...grant to be awarded to Kent State. The grant, whic...stment Act of 2009, runs through 2014. , The gra...ent aquatic resource sensing (EARS). The purpose o...
(Date:11/4/2009)...tural science) , United States Using Less Wate...ay than it did 35 years ago, despite a 30 percent ...tly attributable to alternative cooling methods at...s. According to the latest USGS water use report, ... goes to cooling thermoelectric power plants. Irri...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing 13384 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3
...pert at Johns Hopkins who has spent nearly three d...nfection known as Rocky Mountain spotted fever war...rial disease in Arizona is a growing and dangerous...infectious organisms beyond traditional state boun... England Journal of Medicine, the Hopkins patholog...
...h Institute have found that three bacterial specie... cancer--a discovery the researchers hope will lea...disease. , The findings also open the question of...l role. , The current discovery, reported in the J...that elevated levels of three particular bacteria ...
...nt a great advance for human health. It is based o...NOXIDE system, used in refrigeration towers of fac... be the focus for the proliferation of Legionnaire... team of INASMET-Tecnalia experts designed a refri...olated laboratory (P2 level). A wide range of tria...
Other Biology News:Infectious disease expert warns of spread of Rocky Mountain spotted fever 2Infectious disease expert warns of spread of Rocky Mountain spotted fever 3Forsyth scientists find three bacteria associated with oral cancer 2Forsyth scientists find three bacteria associated with oral cancer 3
(Date:11/5/2009)..., November 5, 2009 at 4:30 p.m. Eastern Time ,,...stCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGe...rted unaudited financial results for the third qua...reviewed the Company,s highlights for the third qu...sults reflect the operations of OncoGenex Technolo...
(Date:11/5/2009)...2009 Senomyx, Inc. (Nasd...y taste receptor-based technologies to discover no... ingredient supply industries, today provided a co...the third quarter ended September 30, 2009. Reven...9, compared to $4.0 million for the third quarter ...
(Date:11/5/2009)...urgery and vision correction experts listed in the...volved at the recently concluded American Academy ...Francisco, California. Dr. Stephen Brint, MD, Dr. ...MD, Dr. Peter Rapoza, MD, Dr. Michael Raizman, MD,...Dr. Edward Manche, MD, and Dr. Parag Majmudar, MD,...
(Date:11/4/2009)...Newswire-FirstCall/ -- Star Scientific, Inc . (...lans to introduce the CigRx(TM) nutraceutical prod...ceuticals, for worldwide marketing and sales in pa...VTIV). inVentiv Health offers a complete range of...e product lifecycle, in a range of healthcare cate...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4
...ober 6, 2008 at 3:00 p.m. EDT, BROOMFIELD, Colo.,... company developing genetically-targeted therapies...es, today announced that,Richard Brewer, the compa.... Michael Bristow, M.D., ARCA,s chairman and chief...Third Annual JMP Securities Healthcare Focus,Confe...
...erapy in U.S. to be Indicated ...ell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC...ntal,Biologics License Application (sBLA) with the...f Zevalin(R) ([90Y]-ibritumomab tiuxetan) as,conso...iously untreated,patients with follicular non-Hodg...
...No. 40/2008, - To OMX Nordic Exchange Copenhagen ...t of license to Roche Diagnostics for,use of the U...oprietary,LNA(TM) detection technology., Roche Di...alTime ready,qPCR assays with the Universal ProbeL...M) detection technology., "This extension of our ...
Other Biology Technology:ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 2ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 3ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 4ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 5Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 2Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 3Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 4Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 5Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 2Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 3
Anti-Cytomegalovirus (CMV) Immediate Early Antigen Monoclonal Antibody, Unconjugated, Clone 3G9.2 from CHEMICON
Goat Anti-DRAK 2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
... proprietary high-performance desalting resin, exc...g and protein-recovery characteristics compared to...aining as low as 25 g/ml of protein can be process...5% retention of salts and other small molecules ( ...
Biology Products: